Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Abciximab

3

III.a Alveolar hemorrhage (AH), diffuse AH (DAH)

3
Last update : 09/10/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Antiplatelet agents: Glycoprotein IIb/IIIa inhibitors
3
Clopidogrel
2
Dabigatran
2
Tiopronine
1

Publications

Be aware of misdiagnosis tied to COVID-19 focusing: a case report of abciximab-induced alveolar haemorrhage thought to be SARS-CoV-2 in a patient with ST-segment elevation myocardial infarction.
European heart journal. Case reports 2020 Dec;4;1-6 2020 Dec
Abciximab-induced alveolar hemorrhage treated with rescue extracorporeal membranous oxygenation.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2015 Apr;85;828-31 2015 Apr
Pulmonary hemorrhage and acute pulmonary thromboembolism after abciximab administration.
The American journal of emergency medicine 2013 Feb;31;450.e1-2 2013 Feb
A retrospective analysis and case series of glycoprotein IIb/IIIa inhibitor associated diffuse alveolar hemorrhage: two case reports.
Cases journal 2009 Jul 30;2;8553 2009 Jul 30
Abciximab-induced alveolar hemorrhage after percutaneous coronary intervention.
The Canadian journal of cardiology 2008 Feb;24;149-51 2008 Feb
A case report of alveolar haemorrhage associated with severe thrombocytopenia induced by abciximab infusion in a patient with an acute coronary syndrome.
Internal and emergency medicine 2008 Dec;3;345-7 2008 Dec
Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors.
Journal of interventional cardiology 2006 Aug;19;356-63 2006 Aug
Abciximab and fatal pulmonary hemorrhage.
Heart & lung : the journal of critical care 2006;35;423-6 2006
Fatal pulmonary haemorrhage with the combined use of abciximab and fibrinolytic agent.
Singapore medical journal 2002 Nov;43;587-9 2002 Nov
Pulmonary hemorrhage after percutaneous coronary intervention with abciximab therapy.
Mayo Clinic proceedings 2002 Dec;77;1340-3 2002 Dec
Alveolar hemorrhage as a complication of treatment with abciximab.
Chest 2001 Jul;120;126-31 2001 Jul
Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2000 Feb;49;181-4 2000 Feb
Fatal alveolar hemorrhage and Abciximab (ReoPro) therapy for acute myocardial infarction.
Catheterization and cardiovascular diagnosis 1998 Jul;44;313-6 1998 Jul

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies